Written Statement: Integration of vaccines administered overseas and outside of Wales into Welsh systems and the NHS COVID Pass

I am writing to provide an update on the integration of vaccinations authorised for use in the UK (by the MHRA – Medicines and Health Care Products Regulatory Agency) administered overseas and outside of Wales into Welsh systems and the NHS COVID Pass.

I am pleased to announce that the Cardiff and the Vale University Health Board pilot was successful and following the receipt of their findings and after discussions with the Health Boards in Wales, I have agreed the rollout of the scheme on a national basis. 

Health Boards will start updating information from residents in their area who are registered with a Welsh GP and have received one or more vaccines outside of Wales.  Initially, evidence will be restricted to the following vaccines approved for use in the UK:

• Oxford/AstraZeneca (Vaxzevria)
• Pfizer/BioNTech (Comirnaty)
• Moderna (Spikevax)
• Novavax (Nuvaxovid)

Included in the scheme are Welsh citizens who received a dose or number of doses of vaccines in Scotland, Northern Ireland and England. Citizens will need to provide information to validate their identity and vaccination evidence.  Citizens should contact their local Health Board for further information:

We will continue to work with stakeholders to develop a system that can record other vaccinations and will confirm arrangements in due course. Individuals who have received vaccinations not currently listed should continue to use the evidence provided at the time of vaccination.

This statement is being issued during recess in order to keep members informed. Should members wish me to make a further statement or to answer questions on this when the Senedd returns I would be happy to do so.